SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-006126
Filing Date
2012-01-30
Accepted
2012-01-30 17:20:20
Documents
2
Period of Report
2012-01-19

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c26990_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c26990_3x1.xml 3 1524
2 POWER OF ATTORNEY c26990_24.htm EX-24 6291
  Complete submission text file 0001209191-12-006126.txt   9178
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 675765 RANCHO SANTA FE CA 92067
Business Address
Zarrabian Saiid (Reporting) CIK: 0001495521 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 12556524